Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome

Ling Ling; Sean M. Bagshaw; Pierre-Marc Villeneuve

doi:10.1503/cmaj.210947

Article Information

vol. 193 no. 46 E1766-E1769

DOI

https://doi.org/10.1503/cmaj.210947

PubMed

34810163

History

Published online November 21, 2021.

© 2021 CMA Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Ling Ling, MD,
Sean M. Bagshaw, MD MSc,
Pierre-Marc Villeneuve, MD MSc

Department of Medicine, Faculty of Medicine and Dentistry (Ling, Bagshaw), University of Alberta and Alberta Health Services; Department of Critical Care and Medicine, Division of Internal Medicine (Villeneuve), University of Alberta and Grey Nuns Hospitals, Edmonton, Alta.

Correspondence to: Pierre-Marc Villeneuve, pierremarc.villeneuve{at}albertahealthservices.ca

Statistics from Altmetric.com

Usage statistics: November 2021 to January 2023

	Full	Pdf
Nov 2021	4486	382
Dec 2021	3216	162
Jan 2022	2334	130
Feb 2022	884	75
Mar 2022	737	64
Apr 2022	496	44
May 2022	524	57
Jun 2022	610	37
Jul 2022	475	26
Aug 2022	382	15
Sep 2022	306	33
Oct 2022	312	82
Nov 2022	263	60
Dec 2022	197	27
Jan 2023	169	29